Sumitomo Mitsui Trust Group Inc. increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 451,544 shares of the medical device company's stock after purchasing an additional 7,681 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.23% of Cooper Companies worth $41,510,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Fulton Bank N.A. lifted its stake in Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after buying an additional 109 shares during the last quarter. Mitchell & Pahl Private Wealth LLC lifted its stake in Cooper Companies by 1.5% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company's stock valued at $881,000 after buying an additional 117 shares during the last quarter. Bleakley Financial Group LLC lifted its stake in Cooper Companies by 2.1% in the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company's stock valued at $636,000 after buying an additional 119 shares during the last quarter. Mather Group LLC. lifted its stake in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after buying an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its stake in Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock valued at $93,000 after buying an additional 136 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.
Cooper Companies Stock Down 6.0 %
Shares of Cooper Companies stock traded down $5.58 during trading on Friday, hitting $88.10. 3,052,861 shares of the stock traded hands, compared to its average volume of 1,313,185. The stock has a market cap of $17.58 billion, a P/E ratio of 45.18, a PEG ratio of 2.41 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company has a fifty day moving average price of $93.94 and a two-hundred day moving average price of $99.73.
Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period last year, the business earned $0.87 EPS. The firm's revenue was up 9.8% compared to the same quarter last year. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the company. StockNews.com lowered Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, December 6th. Wells Fargo & Company raised their price target on Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, December 6th. Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a report on Friday, December 6th. Finally, Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus target price of $117.00.
View Our Latest Stock Report on COO
Cooper Companies Profile
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
